NCT05646680

Brief Summary

The goal of this clinical trial is to test the quality of the performance of opportunistic salpingectomies in women scheduled for adnexectomy. The main questions it aims to answer are:

  • How many salpingectomies are incomplete?
  • Are there any factors related to incomplete resection? Could the investigators develop a instruction video to optimize the surgical technique? Participants planned for uni-or bilateral adnexectomy (removal of ovary and salpinx) will have their adnexectomy in two steps in the same surgical episode: first the salpingectomy (removal of the salpinx), then the oophorectomy (the removal of the ovary).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2022

Completed
15 days until next milestone

Study Start

First participant enrolled

December 9, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2025

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2025

Completed
Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

2.3 years

First QC Date

November 24, 2022

Last Update Submit

January 27, 2026

Conditions

Adnexal LesionOvarian Cancer

Keywords

salpingectomy

Outcome Measures

Primary Outcomes (1)

  • Percentage of incomplete salpingectomies

    The rate of ovarian samples on which residual fimbrial or fallopian tube tissue has been left behind.(macroscopically and microscopically)

    10 days

Study Arms (1)

two step adnexectomy

OTHER

Patients planned for unilateral or bilateral adnexectomy (removal of ovary and salpinx) will have their adnexectomy performed in two steps in the same surgical episode: first the salpingectomy (removal of the salpinx), then the oophorectomy (the removal of the ovary).

Procedure: two step adnexectomy

Interventions

two step adnexectomyPROCEDURE

instead of standard resection of salpinx and ovary, they are now separately excised

two step adnexectomy

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsonly female patients receive hysterectomy
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for uni- or bilateral adnexectomy. (may be in combination with hysterectomy) AND \* competent to act on itself
  • dutch speaking
  • signed informed consent

You may not qualify if:

  • \* Endometrial cancer or invasive cervical cancer
  • radiotherapy in the pelvis in the medical history
  • (partial) salpingectomy
  • Pelvic Inflammatory Disease
  • Adnexectomy for gender transformation surgery if wish to preserve the ovarian tissue.
  • Surgery in two steps is not safe to perform
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Ghent, 9000, Belgium

Location

MeSH Terms

Conditions

Ovarian Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2022

First Posted

December 12, 2022

Study Start

December 9, 2022

Primary Completion

April 12, 2025

Study Completion

April 25, 2025

Last Updated

January 29, 2026

Record last verified: 2026-01

Locations

BE(1)